Keyphrases
Atorvastatin
100%
Adipocyte
100%
Liver X Receptor
100%
Vildagliptin
100%
Cholesterol Efflux
100%
Statins
71%
High-density Lipoprotein Cholesterol (HDL-C)
57%
ATP-binding Cassette Transporter A1 (ABCA1)
57%
ABCG1
57%
Hypertriglyceridemia
28%
Diabetic
14%
Receptor Expression
14%
Triglycerides
14%
Combination Therapy
14%
Peripheral Tissues
14%
Low-density Lipoprotein Cholesterol (LDL-C)
14%
Plasma Parameters
14%
Statin Therapy
14%
3T3-L1 Adipocytes
14%
Antidiabetic Drugs
14%
Synthetic Ligands
14%
Triglyceride-lowering
14%
LDL-C Reduction
14%
Dyslipidemic Patients
14%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
14%
Pharmacology, Toxicology and Pharmaceutical Science
Effusion
100%
Pravastatin
100%
Vildagliptin
100%
Liver X Receptor
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Statin (Protein)
50%
Triacylglycerol
33%
Antidiabetic Agent
16%
Combination Therapy
16%
ABC Transporter
16%
Liver X Receptor Agonist
16%